Core One Labs (XCNQ:COOL) Retained Earnings : C$-166.70 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Core One Labs Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Core One Labs's retained earnings for the quarter that ended in Dec. 2023 was C$-166.70 Mil.

Core One Labs's quarterly retained earnings declined from Dec. 2022 (C$0.00 Mil) to Sep. 2023 (C$-166.27 Mil) and declined from Sep. 2023 (C$-166.27 Mil) to Dec. 2023 (C$-166.70 Mil).

Core One Labs's annual retained earnings declined from Dec. 2019 (C$-51.89 Mil) to Dec. 2020 (C$-106.51 Mil) and declined from Dec. 2020 (C$-106.51 Mil) to Dec. 2021 (C$-144.67 Mil).

Core One Labs Retained Earnings Historical Data

The historical data trend for Core One Labs's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core One Labs Retained Earnings Chart

Core One Labs Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Retained Earnings

Get a 7-Day Free Trial

-18.14

-30.43

-51.89

-106.51

-144.67

Core One Labs Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23	Dec23
Retained Earnings	Get a 7-Day Free Trial															-156.67	-157.86	-	-166.27	-166.70

Core One Labs Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Core One Labs (XCNQ:COOL) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Core One Labs (XCNQ:COOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Core One Labs Inc (XCNQ:COOL) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

CLABF:USA LD6:Germany

Address

1199 West Hastings Street, Suite 800, Vancouver, BC, CAN, V6E 3T5

Website

https://www.core1labs.com

Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.

Executives

Joel Shacker

Director, Senior Officer